BIOCYTOGEN-B Appoints Liu Hongkang as Non-Executive Director
Stock News
Feb 12
BIOCYTOGEN-B (02315) announced that Mr. Liu Hongkang has been appointed as a non-executive director, effective February 12, 2026, until the conclusion of the second board of directors' term. The appointment was approved by shareholders at an extraordinary general meeting. During a board meeting held on January 27, 2026, the board reviewed and approved Mr. Liu's appointment to the audit committee and the strategic development committee, contingent upon shareholder approval of his role as non-executive director. His committee memberships will take effect from the date his election to the board is approved and will last until the end of the second board's term.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.